DCSIMG
LOVENOX®-DVT-Assess Risk
KNOW LOVENOX®

Assess Your Risk of DVT Blood Clots

If you are receiving epidural or spinal anesthesia or undergoing spinal puncture, and taking LOVENOX®, you may be at increased risk of developing a blood clot in or around the spine, which can result in long-term paralysis. Your risk may be further increased if you:

  • Take nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, or other anticoagulants, such as aspirin or blood thinners
  • Have an indwelling epidural catheter
  • Have a history of spinal trauma, or repeated spinal anesthesia or punctures
  • Have a history of spinal deformities or spinal surgery

It is important to contact your doctor immediately if you experience symptoms such as tingling, numbness (especially in the lower limbs), and muscular weakness.

How to Self Inject LOVENOX®

You or a loved one could be at risk for developing deep vein thrombosis (DVT blood clots). There are certain surgeries and medical conditions that may increase your risk. Please see the indications for LOVENOX® below. The first step of defense is to stay informed.

Take the DVT Risk Assessor

Take a moment to complete the following series of questions, then print the results. You can also download a PDF of this Risk Assessor to print out and fill in manually. Your healthcare professional may want to keep a copy of this assessment, in either format, in your file for future reference. Be sure to talk with your healthcare professional about your risk for developing DVT blood clots and whether LOVENOX® may be right for you.

Adapted with permission from Caprini JA, Arcelus JI, et al. State-of-the-art venous thromboembolism prophylaxis. Scope. 2001;8:228-240.

View Transcript

Only your healthcare professional can determine your actual risk.

Talking to your doctor about the risk of developing DVT blood clots is the first step toward staying informed.

DVT Risk Assessor   Download a PDF of the DVT Risk Assessor

You need the Adobe® Reader® installed on your computer to view PDF documents. You can download a copy of the Adobe® Reader® by clicking the link below.

Adobe Download Page

Adobe® and Adobe® Reader® are registered trademarks of Adobe Systems Incorporated.



Important Safety Information for LOVENOX®

If you are receiving epidural or spinal anesthesia or undergoing spinal puncture, and taking LOVENOX® (enoxaparin sodium injection), you may be at increased risk of developing a blood clot in or around the spine, which can result in long-term paralysis. Your risk may be further increased if you:

  • Take nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, or other anticoagulants, such as aspirin or blood thinners
  • Have an indwelling epidural catheter
  • Have a history of spinal trauma, or repeated spinal anesthesia or punctures
  • Have a history of spinal deformities or spinal surgery

It is important to contact your doctor immediately if you experience symptoms such as tingling, numbness (especially in the lower limbs), and muscular weakness.

LOVENOX® should not be used in patients who are actively bleeding or who have a low count of blood cells called platelets, which aid in clotting. This is a condition called "thrombocytopenia." LOVENOX® also should not be used in patients who are allergic or sensitive to LOVENOX® or enoxaparin, heparin, or pork products.

LOVENOX® must be used with care in patients who have any of the following: problems with clotting, uncontrolled high blood pressure, a recent ulcer, impaired vision due to diabetes, kidney problems, and excessive bleeding. Pregnant women with mechanical prosthetic (artificial) heart valves may be at higher risk for blood clots. These patients who are treated with LOVENOX® must be carefully monitored by their doctor.

Some patients on LOVENOX® can experience drops in their platelet counts, a condition called "thrombocytopenia." Also, a serious but rare condition called "heparin-induced thrombocytopenia" can occur with LOVENOX®. If you have had this condition, you must notify your healthcare professional.

LOVENOX® alters the blood’s ability to clot. Excessive bleeding (hemorrhage), leading to death, has occurred with LOVENOX®. Bleeding can occur at any site with LOVENOX® use. The use of aspirin and other NSAIDs may enhance the risk of excessive bleeding. Be sure to tell all your doctors and dentist about all of the medications you are taking, including those you are taking without a prescription, such as aspirin or other NSAIDs. Also be sure to tell your doctor or dentist you are taking LOVENOX® before any surgery is scheduled and before any new drug is taken.

All patients should be carefully monitored by their doctor while taking LOVENOX®. Your doctor is likely to obtain blood tests that measure your blood count and check for signs of hidden bleeding while you are on LOVENOX®.

You should call your doctor immediately if you notice any of the following: unusual bleeding or bleeding that lasts a long time, unusual bruising, signs of thrombocytopenia (such as a rash or dark spots under the skin), tingling or numbness (especially in the lower limbs), and muscular weakness.

The most common side effects from the use of LOVENOX® are mild pain, irritation, bruising, or redness of the skin at the site of injection. Other common side effects include bleeding, anemia, diarrhea, and nausea.

Do not stop taking LOVENOX® without first talking to the doctor who prescribed it for you.

For specific questions about your health, you should always consult your doctor or a qualified healthcare professional who is responsible for your care.

For more information, call sanofi-aventis U.S. Medical Information Services at 1-800-633-1610.


Indications

LOVENOX® can help reduce the risk of developing DVT blood clots, which may lead to PE, in patients undergoing abdominal surgery, hip- or knee-replacement surgery, or in acutely ill medical patients with severely restricted mobility.

Please see Full Prescribing Information, including boxed WARNING, for additional important information.

Prescription LOVENOX® is available in pharmacies.

Click here for information on Sharps Medical Waste Disposal.